NCT03418948

Brief Summary

The aim of this international multicenter study is to compare the adenoma detection rate and adenoma miss rate of conventional and Endocuff Vision-assisted colonoscopy.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
708

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2017

Typical duration for not_applicable

Geographic Reach
2 countries

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 8, 2017

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

December 18, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 1, 2018

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
Last Updated

February 1, 2018

Status Verified

December 1, 2017

Enrollment Period

1.7 years

First QC Date

December 18, 2017

Last Update Submit

January 25, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Adenoma miss rate (%)

    To compare adenoma miss rates (AMR) between Endocuff Vision®-assisted colonoscopy (EAC) and conventional colonoscopy (CC)

    18 months

Secondary Outcomes (12)

  • Adenoma detection rate (%)

    18 months

  • Mean number of adenomas detected per colonoscopy procedure

    18 months

  • Number of sessile serrated lesions per procedure

    18 months

  • Total number of colon lesions found during first and second examination

    18 months

  • Difference in ADR (learning curve first 20% and last 20% by each colonoscopist)

    18 months

  • +7 more secondary outcomes

Study Arms (4)

2 x CC

ACTIVE COMPARATOR

2 x conventional colonoscopy (CC), back-to-back design

Device: 2x CC

CC followed by EC

ACTIVE COMPARATOR

Conventional colonoscopy followed by Endocuff Vision- assisted colonoscopy, back-to-back design

Device: CC followed by EC

EC followed by CC

ACTIVE COMPARATOR

Endocuff Vision-assisted colonoscopy followed by conventional colonoscopy, back-to-back design

Device: EC followed by CC

2 x EC

ACTIVE COMPARATOR

2 x Endocuff Vision-assisted colonoscopy

Device: 2x EC

Interventions

CC = conventional colonoscopy EC = endocuff assisted colonoscopy

CC followed by EC

CC = conventional colonoscopy EC = endocuff assisted colonoscopy

EC followed by CC
2x ECDEVICE

EC = endocuff assisted colonoscopy

2 x EC
2x CCDEVICE

CC = conventional colonoscopy

2 x CC

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients, aged between 40 and 75-years old, referred and scheduled for either screening (non-FIT/gFOBT based), diagnostic or surveillance colonoscopy.

You may not qualify if:

  • Prior surgical resection of any portion of the colon or a history of radiotherapy for any abdominal or pelvic disease.
  • Personal history of colon cancer or polyposis syndrome.
  • Familial adenomatous polyposis (FAP)
  • Known colitis or suspicion of colitis (ulcerative colitis, Crohn's colitis, diverticulitis, infective colitis).
  • Lower gastro-intestinal bleeding requiring acute intervention.
  • Suspicion of large bowel obstruction or toxic megacolon.
  • Prior incomplete colonoscopy (not including insufficient preparation).
  • Patients referred for a therapeutic procedure or assessment of a known non-resected lesion.
  • Not sufficiently corrected anticoagulation disorders
  • Poor general condition (\>3 American Society of Anesthesiologist)
  • Overweight (\>120 kg)
  • Inability to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

"Attikon" University General Hospital,

Athens, Haidari, GR-12462, Greece

RECRUITING

417 Army Veterans Hospital

Athens, 11521, Greece

RECRUITING

Radboud University Medical Center

Nijmegen, Gelderland, 6525GA, Netherlands

RECRUITING

Related Publications (1)

  • van Keulen KE, Papanikolaou IS, Mak TWC, Apostolopoulos P, Neumann H, Delconte G, Furnari M, Peters Y, Lau JYW, Polymeros D, Schrauwen RWN, Cavalcoli F, Koukoulioti E, Triantafyllou K, Anderson JC, Pohl H, Rex DK, Siersema PD. Comparison of adenoma miss rate and adenoma detection rate between conventional colonoscopy and colonoscopy with second-generation distal attachment cuff: a multicenter, randomized, back-to-back trial. Gastrointest Endosc. 2024 May;99(5):798-808.e3. doi: 10.1016/j.gie.2023.11.017. Epub 2023 Nov 20.

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Peter D Siersema, MD

    Radboud University Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Participants will be blinded for the allocation. Physicians can not be blinded for the use of Endocuff, but during the first procedure they will be blinded for the second procedure method to limit observer related bias.
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2017

First Posted

February 1, 2018

Study Start

December 8, 2017

Primary Completion

September 1, 2019

Study Completion

November 1, 2019

Last Updated

February 1, 2018

Record last verified: 2017-12

Locations